Bradley Allen Kreger

Bradley Allen Kreger (chief executive) discloses dealings in 2 companies, chiefly Velo3D, Inc. and Standard Biotools Inc. We count 26 filings; the first trade dates from 20 May 2021 and the latest from 15 May 2025.

Every open-market trade on record is a sale: 2 sales worth €17k. Besides market trades, the filings include 24 option exercises.

The latest filing, published on 16 May 2025, reports an option exercise in Velo3D, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.